{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-030037","form_type":"8-K","ticker":"HTCR","cik":"0001892322","company_name":"HeartCore Enterprises, Inc.","filed_at":"2026-06-25T12:30:16+00:00","discovered_at":"2026-06-25T12:35:00.298204+00:00","generated_at":"2026-06-25T12:35:57.355887+00:00","sec_items":["1.01","2.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"HeartCore divests 51% Sigmaways stake, debt for up to $650k; reduces loss exposure","bullets":["HeartCore sold 51% stake in Sigmaways and $2.19M in promissory notes for up to $650k ($1k cash + earn-out).","Sigmaways had a $3.6M shareholders' deficit as of March 31, 2026, and continued operating losses.","Company contributed a $350k SAFE note from Heart-Tech Health to Semaphore as additional consideration.","Earn-out is 10% of Sigmaways revenue over $5.5M within 12 months post-closing.","HeartCore now focuses on Go IPO consulting (3 engagements) and M&A advisory (2 engagements)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-030037","json":"https://secwatch.observer/filing/0001493152-26-030037.json","markdown":"https://secwatch.observer/filing/0001493152-26-030037.md","text":"https://secwatch.observer/filing/0001493152-26-030037.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1892322/000149315226030037/0001493152-26-030037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1892322/000149315226030037/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T12:35:57.355887+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}